Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hartman

Showing results (241-250 of 272) with videos related to

Pageof 28
Sort By:
Oncoimmunology|May 17, 2017
Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapyJun Ren, William R Gwin, Xinna Zhou, et al.
NPJ Vaccines|March 17, 2026
Vector-directed immunity and boosting capacity of VRP-srRNA anti-tumor vaccinesXingru Ma, Robert D Marek, Susannah Gammell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccineTakuya Osada, Christopher Y Woo, Matthew McKinney, et al.
Vaccine|October 18, 2011
Increasing vaccine potency through exosome antigen targetingZachary C Hartman, Junping Wei, Oliver K Glass, et al.
Breast Cancer Research and Treatment|July 10, 2016
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasionAbhijit Mazumdar, Graham M Poage, Jonathan Shepherd, et al.
JCI Insight|February 15, 2022
Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosisLi-Chung Tsao, Erika J Crosby, Timothy N Trotter, et al.
Oncoimmunology|May 4, 2018
Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumorsErika J Crosby, Junping Wei, Xiao Yi Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2012
Predominance of heavily calcified coccolithophores at low CaCO3 saturation during winter in the Bay of BiscayHelen E K Smith, Toby Tyrrell, Anastasia Charalampopoulou, et al.
Molecular Cancer Therapeutics|April 17, 2014
A small molecule that binds and inhibits the ETV1 transcription factor oncoproteinMarius S Pop, Nicolas Stransky, Colin W Garvie, et al.
Research Square|May 4, 2026
Development of a STEAP1-Targeted Prostate Cancer Specific Antibody Drug Conjugate Platform with Immunostimulatory PropertiesJohn Shuhan Wang, Sirajbir S Sodhi, Li-Chung Tsao, et al.
Pageof 28

Showing results (241-250 of 272) with videos related to

Sort By:
Pageof 28
Oncoimmunology|May 17, 2017
Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapyJun Ren, William R Gwin, Xinna Zhou, et al.
NPJ Vaccines|March 17, 2026
Vector-directed immunity and boosting capacity of VRP-srRNA anti-tumor vaccinesXingru Ma, Robert D Marek, Susannah Gammell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccineTakuya Osada, Christopher Y Woo, Matthew McKinney, et al.
Vaccine|October 18, 2011
Increasing vaccine potency through exosome antigen targetingZachary C Hartman, Junping Wei, Oliver K Glass, et al.
Breast Cancer Research and Treatment|July 10, 2016
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasionAbhijit Mazumdar, Graham M Poage, Jonathan Shepherd, et al.
JCI Insight|February 15, 2022
Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosisLi-Chung Tsao, Erika J Crosby, Timothy N Trotter, et al.
Oncoimmunology|May 4, 2018
Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumorsErika J Crosby, Junping Wei, Xiao Yi Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2012
Predominance of heavily calcified coccolithophores at low CaCO3 saturation during winter in the Bay of BiscayHelen E K Smith, Toby Tyrrell, Anastasia Charalampopoulou, et al.
Molecular Cancer Therapeutics|April 17, 2014
A small molecule that binds and inhibits the ETV1 transcription factor oncoproteinMarius S Pop, Nicolas Stransky, Colin W Garvie, et al.
Research Square|May 4, 2026
Development of a STEAP1-Targeted Prostate Cancer Specific Antibody Drug Conjugate Platform with Immunostimulatory PropertiesJohn Shuhan Wang, Sirajbir S Sodhi, Li-Chung Tsao, et al.
Pageof 28